Home
Apply
Team
Companies
Contact
EN
FR
Meet Our Cohort Companies
Altis Labs
Accelerating clinical development with AI so that patients can access the best treatments earlier
Startup Ally
Our Email
Our Website
On LinkedIn
Onc.AI
Bringing clarity to cancer treatment decision-making and pharma clinical development
Startup Ally
Our Email
Our Website
On LinkedIn
9Bio Therapeutics
Engineering next-generation cancer therapies by reprogramming proteins to act selectively within tumors
Cohort 2025
Our Email
Our Website
On LinkedIn
MISO Chip
Using functional precision medicine to reduce clinical trial failures
Cohort 2025
Our Email
Our Website
On LinkedIn
Nanofacile
Accelerating RNA therapy development for faster and more effective results
Cohort 2025
Our Email
Our Website
On LinkedIn
PCare+
Unlocking precision preventive care through AI-enabled pipelines that translate evolving guidelines into action
Cohort 2025
Our Email
Our Website
On LinkedIn
Rime Therapeutics
Hitting the next generation of targets in inflammation and immunology
Cohort 2025
Our Email
Our Website
On LinkedIn
Simmunome
Building a no-code, high-fidelity SaaS platform for AI-driven disease simulations
Cohort 2025
Our Email
Our Website
On LinkedIn
Stereo Biotherapeutics
Improving the efficacy and developability of small-format soluble TCRs to address cellular heterogeneity in diseases
Cohort 2025
Our Email
Our Website
On LinkedIn
Augment Biologics
Using foundational discoveries in glycobiology to transform biologic drug development.
Cohort 2024
Our Email
Our Website
On LinkedIn
Esya
Making brain health screening as routine and accessible as any other essential health check.
Cohort 2024
Our Email
Our Website
On LinkedIn
Hebbian Bio
Unlocking novel treatments and biomarkers for neuro conditions through precision medicine.
Cohort 2024
Our Email
Our Website
On LinkedIn
ImYoo
Powering personalized medicine via big molecular data directly from patients.
Cohort 2024
Our Email
Our Website
On LinkedIn
Inaedis
Manufacturing powdered, thermally stable biologics and vaccines using innovative room-temperature dehydration technology.
Cohort 2024
Our Email
Our Website
On LinkedIn
ModernVivo
Developing software to help research scientists design optimized in vivo models to reduce costs, accelerate timelines, and identify effective therapeutics.
Cohort 2024
Our Email
Our Website
On LinkedIn
Nine Diagnostics
Determining treatment effectiveness and discovering new biology using AI enabled nanosensor technology.
Cohort 2024
Our Email
Our Website
On LinkedIn
Potato AI
Building an AI scientist to speed up discovery.
Cohort 2024
Our Email
Our Website
On LinkedIn
ReSync Bio
Serving as a single source of truth for preclinical operations: coordinating labs, data, and software programs on one platform.
Cohort 2024
Our Email
Our Website
On LinkedIn
StealthCo
Creating the first programmable platform to advance transformative therapies for patients
Cohort 2024
Our Email
Our Website
On LinkedIn
UbiquiTx
Integrating AI, computation, and biological automation to accelerate the design of novel proteome editors.
Cohort 2024
Our Email
Our Website
On LinkedIn
Voyant Bio
Designing precision immunotherapies targeting immune-immune cell interactions to radically improve cancer patient treatment outcomes.
Cohort 2024
Our Email
Our Website
On LinkedIn
Aperture Bio
Combining the study of proteins and their functions to facilitate the development of cancer drugs.
Cohort 2023
Our Email
Our Website
On LinkedIn
Ascent Bio
Optimizing the search for candidate molecules with a pretrained, deep learning, API-oriented platform.
Cohort 2023
Our Email
Our Website
On LinkedIn
Brainify.AI
Optimizing depression treatment through AI-driven precision psychiatry.
Cohort 2023
Our Email
Our Website
On LinkedIn
DANNCE.AI
Transforming patient care and treatment via advanced 3D pose tracking AI to categorize patient mobility and behaviors.
Cohort 2023
Our Email
Our Website
On LinkedIn
DeepSeq.AI
Decoding protein grammar to expedite lead discovery and ensure successful clinical entry.
Cohort 2023
Our Email
Our Website
On LinkedIn
E9 Genomics
Making genomic insights instantaneous, simple, and accessible at every stage of research and therapeutic development.
Cohort 2023
Our Email
Our Website
On LinkedIn
Orbits Oncology
Bring patients into the heart of cancer drug development and personalized medicine.
Cohort 2023
Our Email
Our Website
On LinkedIn
Providentia Technologies
Predicting drug toxicity early with synthetic cell membranes and machine learning algorithms.
Cohort 2023
Our Email
Our Website
On LinkedIn
Readout AI
Assessing the future of preclinical and clinical trials, saving time and money for researchers and companies.
Cohort 2023
Our Email
Our Website
On LinkedIn
Serinus Biosciences
Designing rational combination therapies using AI to overcome clinically-relevant disease resistance mechanisms.
Cohort 2023
Our Email
Our Website
On LinkedIn
Vcreate
Harnessing machine learning and high-throughput assays to discover potent T-cell receptors for currently untreatable cancers.
Cohort 2023
Our Email
Our Website
On LinkedIn
Andson Biotech
Driving the discovery, development and manufacturing of the next generation of advanced therapies.
Cohort 2022
Our Email
Our Website
On LinkedIn
BioCorteX
Understanding drug-bacteria interactions via first-principle computer simulation
Cohort 2022
Our Email
Our Website
On LinkedIn
Celine Bio
Precision AI-Powered platform to maximize patient outcome for complex age-related diseases
Cohort 2022
Our Email
Our Website
On LinkedIn
Deep Forest Sciences
Cutting edge AI/ML tools for drug discovery accessible to scientists in the biotech/pharma industry.
Cohort 2022
Our Email
Our Website
On LinkedIn
Gesund.ai
Building the AI validation infrastructure and highway to robust, safe, and equitable healthcare AI algorithms for all.
Cohort 2022
Our Email
Our Website
On LinkedIn
Magna Labs
Optimizing high-quality bioinformatic software throughout development, accelerating the innovation and delivery of precision science & medicine.
Cohort 2022
Our Email
Our Website
On LinkedIn
Perceiv AI
Developing a multimodal prognostic platform to forecast disease progression in age-related disorders.
Cohort 2022
Our Email
Our Website
On LinkedIn
Polygon Health
Empowering people to turn their health data into an asset.
Cohort 2022
Our Email
Our Website
On LinkedIn
SciMar ONE
Accelerating drug development to help pharma get life-changing therapies to patients faster.
Cohort 2022
Our Email
Our Website
On LinkedIn
Stem Pharm
Providing physiologically relevant in vitro human models of complex neurologic diseases to pharma companies for use in drug discovery and preclinical development.
Cohort 2022
Our Email
Our Website
On LinkedIn
.png)
.svg)
